title: Metastatic signet-ring cell carcinoma of the urinary bladder: A novel management approach to a rare tumour.
abstract: Primary signet-ring cell carcinoma (SRCC) of the urinary bladder, a variant of adenocarcinoma, is exceedingly rare and as a result no gold standard exists for its management. We report a case of primary SRCC of the bladder with recurrent metastases; we utilized an innovative diagnostic approach and the patient exhibited a treatment response to palliative FOLFOX-6 chemotherapy.
authors.affiliation: Department of Urology, University of California, Davis, Sacramento, CA;
authors.forename: Neil
authors.initials: N
authors.lastname: Pugashetti
authors.affiliation: Department of Urology, University of California, Davis, Sacramento, CA;
authors.forename: Stanley A
authors.initials: SA
authors.lastname: Yap
authors.affiliation: Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis, Sacramento, CA;
authors.forename: Primo N
authors.initials: PN
authors.lastname: Lara
authors.affiliation: Department of Pathology, University of California, Davis, Sacramento, CA.
authors.forename: Regina
authors.initials: R
authors.lastname: Gandour-Edwards
authors.affiliation: Department of Urology, University of California, Davis, Sacramento, CA;
authors.forename: Marc A
authors.initials: MA
authors.lastname: Dall'Era